Jiuzhitang Co Ltd
SZSE:000989

Watchlist Manager
Jiuzhitang Co Ltd Logo
Jiuzhitang Co Ltd
SZSE:000989
Watchlist
Price: 7.81 CNY 2.49%
Market Cap: 6.6B CNY
Have any thoughts about
Jiuzhitang Co Ltd?
Write Note

Jiuzhitang Co Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jiuzhitang Co Ltd
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Jiuzhitang Co Ltd
SZSE:000989
Total Liabilities
ÂĄ1.8B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Liabilities
ÂĄ7.2B
CAGR 3-Years
35%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Liabilities
ÂĄ3.4B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
17%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Liabilities
ÂĄ5.6B
CAGR 3-Years
6%
CAGR 5-Years
15%
CAGR 10-Years
17%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Liabilities
ÂĄ15B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Liabilities
ÂĄ1.3B
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiuzhitang Co Ltd
Glance View

Market Cap
6.7B CNY
Industry
Pharmaceuticals

Jiuzhitang Co., Ltd. is engaged in the developing, manufacturing, wholesaling and retailing of Chinese medicines, Chinese medicinal materials, Western medicines, biological pharmaceuticals, biological preparations, chemical raw materials, chemical reagents and health food. The company is headquartered in Beijing, Beijing and currently employs 4,777 full-time employees. The company went IPO on 2000-06-28. is a China-based company principally engaged in the research, development, production and distribution of Chinese patent drugs. The firm provides products through three categories, which include over the counter (OTC) drugs, prescription drugs and comprehensive health series. The Company’s main products include Liuwei Dihuang pills, Xiaoyao pills, Shuxuetong injection, compound Jiangzhi tablets and E-Jiao series health products, among others. The firm distributes its products in domestic market.

Intrinsic Value
13.8 CNY
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Jiuzhitang Co Ltd's Total Liabilities?
Total Liabilities
1.8B CNY

Based on the financial report for Sep 30, 2024, Jiuzhitang Co Ltd's Total Liabilities amounts to 1.8B CNY.

What is Jiuzhitang Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
15%

Over the last year, the Total Liabilities growth was 25%. The average annual Total Liabilities growth rates for Jiuzhitang Co Ltd have been 10% over the past three years , 13% over the past five years , and 15% over the past ten years .

Back to Top